Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuqing Du

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
International Immunopharmacology|October 22, 2025
A study on the mechanism of action of Syringin in the treatment of type 2 diabetes by integrating metabolomics, network pharmacology, molecular docking technology and experimental validationChunlei Wan, Siyu Sun, Yuqing Du, et al.
Frontiers in Immunology|January 23, 2023
Duck TRIM29 negatively regulates type I IFN production by targeting MAVSWeiqiang Li, Yating Song, Yuqing Du, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
International Immunopharmacology|October 22, 2025
A study on the mechanism of action of Syringin in the treatment of type 2 diabetes by integrating metabolomics, network pharmacology, molecular docking technology and experimental validationChunlei Wan, Siyu Sun, Yuqing Du, et al.
Frontiers in Immunology|January 23, 2023
Duck TRIM29 negatively regulates type I IFN production by targeting MAVSWeiqiang Li, Yating Song, Yuqing Du, et al.
Pageof 4